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Phylogenetic analysisAbstract The antimicrobial activity of plant extract of Peganum harmala, a medicinal plant has
been studied already. However, knowledge about bacterial diversity associated with different parts
of host plant antagonistic to different human pathogenic bacteria is limited. In this study, bacteria
were isolated from root, leaf and fruit of plant. Among 188 bacterial isolates isolated from different
parts of the plant only 24 were found to be active against different pathogenic bacteria i.e.
Escherichia coli, Methicillin-resistant Staphylococcus aureus (MRSA), Enterococcus faecium,
Enterococcus faecalis and Pseudomonas aeruginosa. These active bacterial isolates were identified
on the basis of 16S rRNA gene analysis. Total population of bacteria isolated from plant was high
in root, following leaf and fruit. Antagonistic bacteria were also more abundant in root as
compared to leaf and fruit. Two isolates (EA5 and EA18) exhibited antagonistic activity against
most of the targeted pathogenic bacteria mentioned above. Some isolates showed strong inhibition
for one targeted pathogenic bacterium while weak or no inhibition for others. Most of the
antagonistic isolates were active against MRSA, following E. faecium, P. aeruginosa, E. coli and
E. faecalis. Taken together, our results show that medicinal plants are good source of antagonistic
bacteria having inhibitory effect against clinical bacterial pathogens.
 2015 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Medicinal plants are potential source of natural products that
play an important role in preventing different human diseases.
According to a survey of World Health Organization (WHO),70–80% of the world population especially from developing
countries rely on natural products of medicinal plants for their
health care (Akerele, 1993). These natural products are either
produced by plants or their associated microbes. Several
previous studies have reported the beneficial effects of plant
associated microbes. These microbes generally bacteria, are
present in the phyllosphere, rhizosphere or reside inside the
plant in a mutualistic relationship (Strobel et al., 2004). In this
mutualism, bacteria play an important role in plant growth
promotion by increasing nutrients uptake and mineral
solubilization. Furthermore, this interaction helps in protect-
ing host plant against different pathogens (El-Deeb et al.,
2013).Sciences
2 F. BibiIn recent years, bioactive metabolites from medicinal plants
have gained global attention. Bioactive metabolites are
produced by medicinal plant or associated microbes. These
bioactive metabolites are involved in symbiotic association
with the host plant (Strobel, 2003). Bacteria produce bioactive
metabolites exhibiting activities against phytopathogens as
well as against bacteria, fungi, viruses, protozoans affecting
humans and animals (Strobel et al., 2004).
The Kingdom of Saudi Arabia is so wide having more
diverse flora as variation in climate and height of different
area. Different medicinal plants and their extract have antibac-
terial, antifungal, anti-inflammatory activity and are used here
by local people in kingdom in traditional medicine especially in
remote area (Abulafatih, 1987; Al-Said, 1993; Ageel et al.,
1986; Bokhari, 2009; Saadabi, 2006). Hermal (Peganum
harmala L.) is a medicinal plant in the kingdom planta used
in folk medicines due to insecticidal activity (Rharrabe et al.,
2007), inhibition of reproduction (Nath et al., 1993; Adday,
1994), antimicrobial activity, and in cure of different diseases
such as gastrointestinal, hypertension, cardiac, nervous system
disorders, diabetes (Moloudizargari et al., 2013). The plant
extract also shows in vivo and in vitro cytotoxicity in cancer cell
line, rats and mouse model (Lamchouri et al., 2013).
In some previous studies in the kingdom planta many
medicinal plants were used for antimicrobial studies (Alamri
and Moustafa, 2012) but little is known about the distribution
and isolation of bacteria from medicinal plants (El-Deeb et al.,
2013). Therefore, the present study was designed to isolate and
screen bacteria from P. harmala against human pathogenic
bacteria. Furthermore, these potential bacteria were identified
using 16S rRNA gene and phylogenetic analysis was
performed.
2. Materials and methods
2.1. Plant collection and isolation of bacteria
P. harmala samples were collected in March 2014, from Taif
region, Saudi Arabia. After collection, plant specimens were
placed in a sterile bag and transferred to laboratory within
24 h for bacterial isolation. These plant samples were washed
with sterile distilled water to remove soil and root, leaf and
fruit of plant were separated. Bacteria were isolated from each
part after cutting 1.0 g of tissue from each part mentioned
above. These plant tissue samples were ground using sterile
mortar and pestle. This homogenate was used to make serial
dilutions using autoclaved distilled water and 0.1 ml aliquots
were plated out on two different isolation media, 1/2 Tryptic
soy agar and 1/2 R2A agar (HIMEDIA) supplemented with
amphotericin B 25 lg/ml to inhibit fungal growth. These plates
were then incubated at 28 C for 1–2 weeks. Bacterial colonies
were selected based on morphological features such as size,
color and appearance. For pure culture, colonies were
re-streaked and stocks were maintained in 15% (v/v) glycerol
solution and stored at 80 C for further use.
2.2. Screening of bacteria for antibacterial potential
Bacteria isolated from different parts of plants were screened
for antibacterial activity using deferred antagonistic assay. In
brief bacterial isolates were grown at 28 C and 24 h grownPlease cite this article in press as: Bibi, F. Diversity of antagonistic bacteria isolated
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agar mixed with test strains. All test strains were diluted to
final concentration A600 = 0.1. Plates were again incubated
at 28 C for 24 h and the zone of inhibition was documented.
The test strains of bacteria (Escherichia coli ATCC 8739,
MRSA ATCC 43300, Enterococcus faecalis ATCC 29212,
Enterococcus faecium ATCC 27270 and Pseudomonas aerugi-
nosa ATCC 27853) were pregrown in LB broth at 37 C.
2.3. DNA extraction and PCR analysis
The selected strains were subjected to extraction of genomic
DNA for 16S rRNA gene analysis for identification of antag-
onistic bacterial strains. Genomic DNA of selected bacteria
was extracted using commercial genomic DNA extraction kit
(Thermo Scientific, Waltham, USA). The 16S rRNA gene
was amplified from the extracted DNA using bacterial univer-
sal primers 27F (50-AGAGTTTGATCCTGGCTCAG-30) and
1492R (50-GGTTACCTTGTTACGACTT-30). Amplifications
were performed with the following thermal cycle: one cycle
of 95 C for 5 min followed by 30 cycles of 94 C for 1 min,
an annealing of 58 C for 50 s and extension at 72 C for
1 min, with a final extension step at 72 C for 10 min. The
PCR products were separated by agarose gel electrophoresis
and purified using PCR purification kit (Thermo Scientific,
Waltham, USA) according to the manufacturer’s instructions
and were sequenced by Macrogen (Seoul, Korea).
2.4. Phylogenetic analysis of antagonistic bacteria
For taxonomic identification of the antagonistic bacteria, the
16S rRNA gene sequences of all isolates were compared with
sequences of matched type strains obtained from National
Centre for Biotechnology Information (NCBI) and using the
EzTaxon database (http://www.eztaxon.org/; Chun et al.,
2007). The closest type species match was recorded along with
the percent sequence similarity (Table 1). Multiple alignments
were performed by using the CLUSTAL_X program
(Thompson et al., 1997) and gaps were edited by using Bio
Edit (Hall, 1999). The evolutionary distances were calculated
using the Kimura two-parameter model (Kimura, 1983). The
phylogenetic tree were constructed by using a neighbor-
joining method (Saitou and Nei, 1987) in the MEGA4
Program (Tamura et al., 2007) with bootstrap values based
on 1000 replications (Felsenstein, 1985).
2.5. Nucleotide sequence numbers
The nucleotide sequences obtained for 24 bacterial strains in
this study have been deposited in the GenBank database under
accession numbers KR812389 to KR812412.3. Results
3.1. Isolation of antagonistic bacteria from plant
A total of 188 bacteria forming morphologically different colo-
nies were isolated from roots, leaf and fruit of plant. All the
isolated strains from different parts of the plant mentioned
above were cultured on 1/2 TSA and 1/2 R2A. Bacterial countfrom medicinal plant Peganum harmala L. Saudi Journal of Biological Sciences
Table 1 Identification of antagonistic bacterial isolates on the basis of 16S rRNA and their antimicrobial activity against human
pathogenic bacteria.
bAntibacterial activity against
Strain
lab no
Accession
numbers
Closely related type strain a% identity E. coli MRSA P. faecium P. faecalis P. aeruginosa
Root
EA 1 KR812389 Pseudomonas parafulva AJ 2129T 98.60    + 
EA 2 KR812390 Leucobacter chromiiresistens JG 31T 98.60   + + +
EA 3 KR812391 Prolinoborus fasciculus CIP 103579T 98.30     +
EA 4 KR812392 Pantoea dispersa LMG 2603T 97.90   + + 
EA 5 KR812393 Erwinia toletana CECT 5263T 98 + +  + ++
EA 6 KR812394 Erwinia piriflorinigrans CFBP 5888T 98  + +  
EA 7 KR812395 Carnobacterium viridans MPL-11T 97.10   +  
EA 8 KR812396 Pseudomonas cremoricolorata NRIC 0181T 99.30 ++    
EA 9 KR812397 Bacillus subtilis subsp. inaquosorum
KCTC 13429T
98.90    + +
EA 10 KR812398 Bacillus endophyticus 2DTT 98.70 ++    
EA 11 KR812399 Bacillus methylotrophicus CBMB205T 97.60  +   
EA 12 KR812400 Bacillus aryabhattai B8W22T 99.70    + +
EA 13 KR812401 Staphylococcus sciuri subsp. sciuri
DSM 20345T
99.50  +   
EA 14 KR812402 Terribacillus aidingensis YI7–61T 98.90   +  
EA 15 KR812403 Staphylococcus lentus ATCC 29070T 99.40   +  
EA 16 KR812404 Leucobacter chromiiresistens JG 31T 98.40 + ++   ++
EA 17 KR812405 Carnobacterium inhibens K1T 98.60  +   
Leaf
EA18 KR812406 Bacillus endophyticus 2DTT 98.60 ++ + + + +
EA 19 KR812407 Bacillus atrophaeus JCM 9070T 99.80  +   
EA 20 KR812408 Pseudomonas chlororaphis subsp.
piscium JF3835T
97.80 +    
EA 21 KR812409 Bacillus aryabhattai B8W22T 99.70   +  
EA 22 KR812410 Brevibacterium halotolerans DSM 8802T 99.50  + +  
Fruit
EA 23 KR812411 Pseudomonas entomophila L48T 99.60  +   
EA 24 KR812412 Leucobacter chromiiresistens JG 31T 99.50  ++   
a Based on the results of partial 16S rRNA gene sequence analysis of all strains.
b The antibacterial activity was determined by in vitro Double agar overlay method. The activity was estimated after 24 h incubation at 28 C
by measuring the clear zone of bacterial inhibition: +, <3 mm; ++, between 4 and 5 mm; , no activity.
Antagonistic bacteria from medicinal plant 3was high. In terms of plant tissue, the bacterial population was
high from root of the plants (using both media) where 114 bac-
teria were recovered, following leaf (41) and fruit (33). Regard-
ing antagonistic population of bacteria from these total
isolates most of them were isolated from root (71%), following
leaf (21%) and fruit (8%).
3.2. Screening for antibacterial activity
Double agar overlay method was used to test isolated strains
against human pathogenic bacteria. Screening of 188 bacteria
for their ability to inhibit human pathogenic bacterial growth,
only 24 (12.7%) were found to be active. Of the 24 bacteria
examined, only 1 isolate (KR812406) displayed inhibitory
activity to all the pathogenic bacteria tested. Activities of rest
of the isolates vary for different tested bacteria. Table 1 sum-
marizes how each isolate inhibits the growth of bacterial
pathogens tested. The antagonistic isolates EA5 and EA18
had inhibition activity against most of the target pathogens.
These isolates strongly inhibited P. aeruginosa and E. coli
respectively while weakly inhibited the others. From thesePlease cite this article in press as: Bibi, F. Diversity of antagonistic bacteria isolated
(2015), http://dx.doi.org/10.1016/j.sjbs.2015.09.021active isolates, 11 isolates were active against MRSA, follow-
ing 9 against E. faecium, 6 against E. coli, and 7 for P. aerug-
inosa and E. faecalis.
3.3. Identification of antagonistic bacteria on the basis of 16S
rRNA gene sequence and their phylogenetic analysis
The 24 antagonistic bacteria isolated from the plant were fur-
ther identified by partial 16S rRNA gene sequence analysis.
Ten different genera were identified and in turn assigned to
three major classes: Firmicutes (n= 13; 54%), c-
Proteobacteria (n= 8; 33%) and Actinobacteria (n= 3;
13%) (Fig. 1). A phylogenetic tree was generated from the dis-
tance data using the neighbor-joining method with the Jukes
and Cantor model in a MEGA5 Program (Fig. 2). For the
phylogenetic analysis on the basis of 16S rRNA gene,
sequences of isolated strains along with sequences of type
strains of closely related strains of different genera were
included in the data set. Most of the sequenced strains have
16S rRNA gene similarities of 97–99%. Bacterial strains
belonging to class Firmicutes were dominant and furtherfrom medicinal plant Peganum harmala L. Saudi Journal of Biological Sciences
Figure 1 Percentage contribution of different phyla of antago-
nistic bacteria from total population on the basis of 16S rRNA
gene sequence similarity.
4 F. Bibirelated to 5 different genera i.e. Staphylococcus, Carnobac-
terium, Bacillus, Terribacillus and Brevibacterium. Strains
EA51 and EA61 were almost similar to each other. Strains
EA49 and EA58 were identical to each other with a high
bootstrap value (96%) in phylogenetic analysis. The strains
of class c-Proteobacteria were placed in 4 different genera
in the phylogenetic tree. The representatives of class
c-Proteobacteria were identified as Pseudomonas, Prolinoborus,
Pantoea and Erwinia. All these strains of c-Proteobacteria hadFigure 2 Phylogenetic analysis of antagonistic bacteria isolated from
from antagonistic bacteria and closely related sequences of the type s
relationships among taxa were inferred from the 16S rRNA gene by us
Jukes–Cantor algorithm. Bootstrap values of >50% (1000 replicates)
each sequence are shown in parentheses. Bar, 0.01 accumulated chang
Please cite this article in press as: Bibi, F. Diversity of antagonistic bacteria isolated
(2015), http://dx.doi.org/10.1016/j.sjbs.2015.09.021high sequence similarity with already known strains (97–99%).
Representatives of class Actinobacteria belonged to single
genus i.e. Leucobacter.
4. Discussion
A culture-dependent method was used in the present study to
isolate and investigate antagonistic bacteria from P. harmala
against human pathogenic bacteria. The screening of 188
bacteria on the basis of their antagonistic potential against
human pathogenic bacteria and subsequent identification on
partial 16S rRNA gene sequence resulted in a diversity of
different groups of bacteria comprising different genera. In
the present study, it has been seen that medicinal plant
harbored a large fraction of antagonistic bacteria similar as
reported in previous studies (Aravind et al., 2009; Burch and
Sarathchandra, 2006; Li et al., 2012; Preveena and Bhore,
2013). Our results show that bacterial population was high
on TSA media as compared to R2A used in this study. To
our knowledge, this is the first study in P. harmala to study
bacterial diversity and their antagonistic potential against
human pathogens.
P. harmala is a well-known medicinal plant used for its anti-
fungal activities in Saudi Arabia (Saadabi, 2006). Several pre-
vious studies have shown antimicrobial activities of alkaloids
derived from seeds of P. harmala (Moloudizargari et al.,
2013). There is no study so far where antagonistic bacterial
diversity has been analyzed from P. harmala. In this study bac-
terial colonization seems to be abundant in the rhizosphere of
root tissues of plant as root is the primary site to gain entryP. harmala on the basis of 16S rRNA gene sequences obtained
trains representative of other species of genera. The phylogenetic
ing the neighbor-joining method from distances computed with the
are shown next to the branches. GenBank accession numbers for
es per nucleotide.
from medicinal plant Peganum harmala L. Saudi Journal of Biological Sciences
Antagonistic bacteria from medicinal plant 5into the plant tissue (Bloemberg and Lugtenberg, 2001;
Lodewyckx et al., 2002). All parts of plant used in this study
harbored a large fraction (n= 24) of potential bacteria active
against different human pathogenic bacteria tested. Secondary
metabolite production is the phenomenon used by bacteria to
promote plant growth and defend against different soil
pathogens (Dobbelaere et al., 2003; Compant et al., 2005;
Bhore et al., 2010). In previous studies on medicinal plants it
has been seen that each plant harbors a specific kind of bacte-
rial population depending upon their alkaloids and secondary
metabolites produced by associated bacteria (Qi et al., 2012).
Bacterial identification based on the 16S rRNA gene is a
rapid and accurate method for identification of bacterial
population from any source (Clarridge, 2004). Thus, we used
this method for the identification of antagonistic bacteria
isolated in our study. All 16S rRNA gene sequences obtained
from antagonistic bacteria were further analyzed for their phy-
logenetic analysis. Using neighbor-joining phylogenetic method
the tree topology grouped into three different groups:Firmicutes
(Bacillus, Carnobacterium, Staphylococcus, Terribacillus, and
Brevibacterium), c-Proteobacteria (Pseudomonas, Prolinoborus,
Pantoea and Erwinia) and Actinomycetes (Leucobacter) (Figs. 1
and 2). Our results indicated that Firmicutes was the dominant
group in this study based on 16S rRNA gene sequence analysis
(Table 1). This is consistent with some previous studies
(Tamilarasi et al., 2008) while contradictory results have been
also found in some other studies, where the Actinobacteria was
the dominant group in bacterial community analysis from
different medicinal plants (Zhao et al., 2011). Members of
Firmicutes, especially Bacillus are responsible for production
of a wide range of antimicrobial metabolites, enzymes and
surfactants which promote plant growth and induce systemic
resistance in plants (Bibi et al., 2012). Nine isolates were
identified as a member of c-Proteobacteria including mainly
Pseudomonas. The presence of Pseudomonas as a common soil
inhabitant of plant, biocontrol agent and antimicrobial com-
pound producer is already reported (O´ Sullivan and O´ Gara,
1992;Kobayashi et al., 1998). Only three actinobacterial isolates
have been isolated in this study. Species of Actinobacteria have
been isolated in previous studies frommedicinal plants featuring
antimicrobial and antitumor activities (Tamilarasi et al., 2008).
5. Conclusion
In conclusion, the present study demonstrates the phylogenetic
diversity of antagonistic bacteria from medicinal plant. Our
study of antagonistic bacteria of medicinal plants against
human pathogens indicates that these bacteria produce some
metabolites that inhibit different human pathogenic bacteria.
Furthermore, it appears that medicinal plants can be an
important source of antagonistic bacteria that confers many
advantages to host plant. Further investigations are required
to study the associated endophytic bacterial population of host
plant that may be useful similar to rhizospheric bacteria.
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